Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

← The archive

archived as published

Thursday, 1 October · prices through NSE close

PB Fintech shares fall on IRDAI distribution changes, and 5 more corroborated developments

1

PB Fintech shares fall on IRDAI distribution changes

The Insurance Regulatory and Development Authority of India proposed sweeping changes to insurance distribution, commissions, and expense structures. PB Fintech shares declined following the proposal, with insurance stocks experiencing heavy selling as the regulatory changes affect how insurers and distributors earn from policies.

2

US exempts select specialty drugs from pharma tariff

The US government has exempted certain specialty pharmaceutical products and associated ingredients imported from India and 19 other countries from a 100% tariff. The exemption applies to drugs and ingredients used to treat rare medical conditions.

3

ITC completes Yoga Bar parent company acquisition

ITC has completed its acquisition of Sproutlife Foods Private Ltd, the parent company of the Yoga Bar brand, by purchasing the remaining 52.5% stake for approximately ₹645 crore, making it a wholly owned subsidiary. The cumulative investment in the health and nutrition brand totals approximately ₹900 crore.

4

Flipkart expands logistics network for festive season

Flipkart's logistics arm Ekart expanded its storage capacity by 50% and added over 900 delivery hubs, bringing its network to more than 8,200 facilities. The expansion included 14 million cubic feet of warehousing space and extended delivery coverage to over 750 new PIN codes ahead of the upcoming festive season.

5

Indian indices close lower on September 29

6

Reliance Industries raises 13000 crore via bonds

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.